Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int Orthop ; 41(3): 475-480, 2017 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-27826763

RESUMO

PURPOSE: We report clinical and radiological outcome of a dual mobility cup (DMC) of 2nd generation after a minimum of ten year-follow-up (FU). The goal of this work was to compare the results of this DMC in patients aged less than 55 years and in patients aged more than 55 years. METHODS: From 2000 to 2005, a prospective and consecutive series of 119 THAs with a cementless DMC of 2nd generation (GIROS) were performed in patients aged less than 55 years and 444 in patients aged more than 55 years. RESULTS: The mean FU was 11 years (8 to 15 years). Survivorships (failure of both components or cup loosening) were not different between patients aged less than 55 years and patients aged more than 55 years. There was no dislocation. DEVANE classification, Harris, PMA and Oxford scores improved after THA but no difference could be found between between < 55 years and > 55 years patients. CONCLUSION: These results are better than those of first generation (BOUSQUET) DMC (77 % of survival rate at 20 years of FU). These results are in the same agreement than those of the literature: 99 % of survival rate at 14.2 years of FU for KERBOULL with a low friction arthroplasty and 96.5 % at ten years of FU for ceramic/ceramic bearing (R CHANA). The DMC for young patient is a relevant surgical option with no dislocation and excellent clinical results and survival rate at more than ten years of FU.


Assuntos
Artroplastia de Quadril/métodos , Prótese de Quadril/estatística & dados numéricos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Artroplastia de Quadril/efeitos adversos , Feminino , Seguimentos , Luxação do Quadril/cirurgia , Prótese de Quadril/efeitos adversos , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Desenho de Prótese , Taxa de Sobrevida , Resultado do Tratamento , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...